Development and validation of a risk score for serious infection in patients with rheumatic diseases receiving prolonged high-dose glucocorticoids
Se Rim Choi(Seoul National University Bundang Hospital), Jun Won Park(Seoul National University), Yun Jong Lee(Seoul National University), You‐Jung Ha(Seoul National University Bundang Hospital), Jin Kyun Park(Seoul National University), E. Kang(Seoul National University), E. B. Lee(Seoul National University), Ju Yeon Kim(Sungae Hospital)
Cited by 0
Related Papers
HM71224, a novel Bruton’s tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis
|Arthritis Research & Therapy|2016|66
Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort study
|Lara D. Veeken|2019|36
Inhibition of histone deacetylase 6 suppresses inflammatory responses and invasiveness of fibroblast-like-synoviocytes in inflammatory arthritis
|Arthritis Research & Therapy|2021|34
Fucoxanthin Suppresses Osteoclastogenesis via Modulation of MAP Kinase and Nrf2 Signaling
|Marine Drugs|2021|28
Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study
|Arthritis Research & Therapy|2023|28